Men's Health News

RSS

New research suggests pedophiles more likely to have facial anomalies

New research suggests pedophiles are more likely to have superficial facial flaws, known as Minor Physical Anomalies (MPAs). They are also more likely to be left-handed, says Fiona Dyshniku of the University of Windsor in Canada. She led an investigation into the prevalence and distribution of physical anomalies among men who are sent for sexological assessment.

11 Jun 2015

Men benefit from ultrasound screening for abdominal aortic aneurysms

Men benefit from one-time screening for abdominal aortic aneurysms via ultrasound. Studies provide proof that their risk of dying is reduced, the abdominal aorta ruptures less often, and emergency surgery can be avoided more often. Far fewer data are available for women and they show no relevant differences between the groups investigated.

11 Jun 2015

FDA agrees to Oncogenex' proposed amendment to Phase 3 AFFINITY protocol

OncoGenex Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has agreed to the Company's proposed amendment to the Phase 3 AFFINITY protocol and statistical analysis plan.

10 Jun 2015

Pathology expert shares vital information about prostate cancer

Requesting a copy of your pathology report, asking questions of your doctor and playing an active role in decision-making are important ways that men should take control of their health.

10 Jun 2015

Findings underscore the value of emotional, informational support for prostate cancer patients

A study led by the University at Buffalo and Roswell Park Cancer Institute has identified beliefs and personality traits that are associated with higher levels of distress in newly diagnosed prostate cancer patients.

10 Jun 2015

Only 50% of men can remember their last medical check-up, shows new national survey

A new national survey about men and their cars, commissioned by Orlando Health, found that more than 80 percent of men could remember the make and model of their first car, but only about half could remember the last time they went to the doctor for a check-up.

10 Jun 2015

QUT cancer and eye researchers named in Queen's Birthday honours

Professor Clements is honoured for her outstanding contribution to biomedical research, particularly prostate cancer research, and for her success in generating ongoing funding to support the establishment of critically-needed national medical research facilities.

10 Jun 2015

Advanced prostate cancer patients who have AR-V7 gene variant respond to chemotherapy

In a small clinical trial, scientists at Johns Hopkins' Kimmel Cancer Center and James Buchanan Brady Urological Institute found that men with advanced prostate cancer and detection of androgen receptor splice variant-7 (AR-V7) respond to chemotherapy just as well as men who lack the variant.

9 Jun 2015

New statistics show oesophageal cancer rates increase by 50% in men

Oesophageal cancer rates in men have increased by 50 per cent since the early 1980s, with new cases reaching almost 6,000, according to new statistics from Cancer Research UK.

8 Jun 2015

Researchers identify immune system marker that drives therapy-resistant prostate cancer

You are a patient who has just been treated for a serious illness but neither you nor your doctor knows how likely it is that you -- in comparison with other patients -- will actually be helped by the treatment. This is often the situation with prostate cancer, one of the deadliest and most highly prevalent cancers. While hormone therapy can help, patient responses vary widely, and it's still unclear why some types of prostate cancer seem to be resistant to the therapy.

5 Jun 2015

Questionnaire predicts chances of middle-aged people living until 2020

People aged between 40 and 70 years can now answer a set of simple questions to calculate their personalised 5-year mortality risk and what is referred to as an “Ubble age” – the age where the average mortality risk in the population is most similar to the estimated risk...

4 Jun 2015

Scientists produce strongest evidence yet of schizophrenia’s causes

An international team of scientists led by Cardiff University researchers has provided the strongest evidence yet of what causes schizophrenia - a condition that affects around 1% of the global population...

3 Jun 2015

Scar management: an interview with Adele Atkinson, Associate Professor, School of Nursing

Scarring has been shown to have a significant impact on patients’ lives. As well as the physical burden associated with skin scarring, psychological strains can also negatively affect the quality of life for patients, with the majority (56%) considering themselves to be ‘abnormal’ due to their scars...

3 Jun 2015

Survey shows most men with advanced prostate cancer ignore their symptoms as disease progresses

Prostate cancer is the second most common cancer and the second leading cause of cancer-related deaths among men in the U.S...

3 Jun 2015

Rhinoplasty procedure more popular amongst men

Earlier this year, data was released by the American Society for Aesthetic Plastic Surgery (ASAPS) that detailed the rise in male plastic surgery procedures. The overall conclusion was that male procedures had risen 43 percent in the past 5 years.

2 Jun 2015

Heart-healthy diet may benefit men after prostate cancer diagnosis

After a prostate cancer diagnosis, eating a diet higher in red and processed meat, high-fat dairy foods, and refined grains--known as a Western diet--may lead to a significantly higher risk of both prostate cancer-related mortality and overall mortality compared with eating a diet rich in vegetables, fruits, fish, whole grains, and healthy oils, according to a new study from Harvard T.H. Chan School of Public Health.

1 Jun 2015

Smartphone digital ruler ensures correctly-fitting condom

From now on, men around the world can make sure they get the right size condoms by measuring their penis with their smartphone. On the mobile website MeasureYourPenis.today, men can measure the girth of their penis by placing it on a digital ruler. Seven different colour codes representing different girths are used to provide advice and an additional explanation about condom sizes.

1 Jun 2015

OncoGenex's Phase 3 SYNERGY trial shows survival benefits of custirsen therapy in CRPC patients with poor prognosis

OncoGenex Pharmaceuticals, Inc. announced today that results from a retrospective analysis of the Phase 3 SYNERGY trial showed a benefit with custirsen therapy in men with metastatic castrate-resistant prostate cancer (CRPC) who had a poor prognosis.

1 Jun 2015

Decipher Prostate Cancer Classifier predicts metastasis in patients treated with salvage radiation therapy

GenomeDx Biosciences today announced that data presented at the 2015 American Society of Clinical Oncology Annual Meeting demonstrate that the Decipher® Prostate Cancer Classifier is a significant predictor of metastasis in patients treated with postoperative salvage radiation therapy.

30 May 2015

New combination chemotherapy may become clinical standard for metastatic castrate-resistant prostate cancer

For more than a decade, oncologists using cytotoxic chemotherapy to treat patients with advanced metastatic castration-resistant prostate cancer (mCRPC) have relied on the sequential use of single agent taxanes such as docetaxel and cabazitaxel. For example, docetaxel is commonly used as the "first-line" therapy, while cabazitaxel is used as the "second-line" therapy.

30 May 2015

Men's Health News

New research suggests pedophiles more likely to have facial anomalies

Men benefit from ultrasound screening for abdominal aortic aneurysms

FDA agrees to Oncogenex' proposed amendment to Phase 3 AFFINITY protocol

Pathology expert shares vital information about prostate cancer

Findings underscore the value of emotional, informational support for prostate cancer patients

Only 50% of men can remember their last medical check-up, shows new national survey

QUT cancer and eye researchers named in Queen's Birthday honours

Advanced prostate cancer patients who have AR-V7 gene variant respond to chemotherapy

New statistics show oesophageal cancer rates increase by 50% in men

Researchers identify immune system marker that drives therapy-resistant prostate cancer

Questionnaire predicts chances of middle-aged people living until 2020

Scientists produce strongest evidence yet of schizophrenia’s causes

Scar management: an interview with Adele Atkinson, Associate Professor, School of Nursing

Survey shows most men with advanced prostate cancer ignore their symptoms as disease progresses

Rhinoplasty procedure more popular amongst men

Heart-healthy diet may benefit men after prostate cancer diagnosis

Smartphone digital ruler ensures correctly-fitting condom

OncoGenex's Phase 3 SYNERGY trial shows survival benefits of custirsen therapy in CRPC patients with poor prognosis

Decipher Prostate Cancer Classifier predicts metastasis in patients treated with salvage radiation therapy

New combination chemotherapy may become clinical standard for metastatic castrate-resistant prostate cancer

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News